U.S. Medical Equipment Stock News

NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

Baidu’s AI Businesses Take Lead As Margins Lag And Apollo Grows

Baidu reports that its core AI powered businesses now account for more than half of general business revenue for the first time. The shift is linked to rapid progress in AI agents such as DuMate, Miaoda, Yijing, and Famou 2.0, along with a broader international rollout. Baidu’s autonomous ride hailing service, Apollo Go, has expanded to 27 cities, marking a wider commercial footprint in AI driven mobility. Baidu (NasdaqGS:BIDU) is trading at $127.79, with the stock up 52.5% over the past...
NYSE:ORCL
NYSE:ORCLSoftware

Will Oracle's New AI-Focused Cloud Deals and Samsung Java Alliance Change Oracle's (ORCL) Narrative

In May 2026, Oracle announced a string of developments including new healthcare and telecom partnerships, participation in an expanded beam optical connectivity alliance, a major Java standardization deal with Samsung, and the appointment of Cleveland Clinic CEO Dr. Tomislav Mihaljevic to its board. These moves collectively highlight Oracle’s push deeper into AI-ready cloud infrastructure and mission-critical industries, from semiconductor design to hospital systems and telecom...
NYSE:LNG
NYSE:LNGOil and Gas

Assessing Cheniere Energy (LNG) Valuation As Long Term Returns Outpace Recent Share Price Moves

Cheniere Energy (LNG) has drawn investor attention after recent price moves, with the stock roughly flat over the past day, lower over the past week and month, but higher over the past three months. See our latest analysis for Cheniere Energy. At a share price of $240.85, Cheniere Energy has a year to date share price return of 21.76%, while the 1 year total shareholder return of 6.15% contrasts with a much stronger 78.59% total shareholder return over three years. This suggests that long...
NasdaqGS:ALAB
NasdaqGS:ALABSemiconductor

Assessing Astera Labs (ALAB) Valuation After Analyst Upgrades And Jim Cramer Spotlight

Astera Labs stock in focus after upbeat commentary Astera Labs (ALAB) has moved into the spotlight after favorable analyst coverage and a positive mention from Jim Cramer, drawing fresh attention to its role in semiconductor and AI infrastructure. See our latest analysis for Astera Labs. The recent analyst endorsements and positive TV coverage have coincided with very strong trading momentum, with a 7 day share price return of 42.35% and a 90 day share price return of 139.00% pushing the...
NYSE:UDR
NYSE:UDRResidential REITs

Assessing UDR (UDR) Valuation As Recent Trading And Modest Undervaluation Signals Converge

How UDR stock has been trading recently UDR (UDR) has drawn investor attention after its recent share performance, with the stock last closing at US$38.01. Short term and longer term returns have varied, giving a mixed picture of momentum. See our latest analysis for UDR. Recent share price moves have been steady rather than dramatic, with a 1-month share price return of 9.32% and a 1-year total shareholder return of 0.91%. This suggests that momentum is still forming rather than fully...
NYSE:OHI
NYSE:OHIHealth Care REITs

Is It Too Late To Consider Omega Healthcare Investors (OHI) After Its Strong Multi Year Run?

Investors may be asking whether Omega Healthcare Investors at US$47.90 still offers value after a strong run, or if they might be late to the story. The stock is slightly down 0.9% over the past week, while returns sit at 3.2% over 30 days, 7.6% year to date, 40.8% over 1 year and 94.8% over 5 years. This mix often prompts investors to revisit what they are really paying for. Recent coverage has focused on Omega Healthcare Investors as a healthcare focused REIT, with attention on how its...
NasdaqGS:NDSN
NasdaqGS:NDSNMachinery

A Look At Nordson (NDSN) Valuation After Earnings Beat And Upgraded Outlook

Nordson (NDSN) has drawn fresh attention after reporting second quarter earnings and updating guidance, combining higher sales and earnings with increased full year and third quarter revenue expectations, supported by stronger backlog and order momentum. See our latest analysis for Nordson. The recent earnings beat and higher guidance appear to be feeding into sentiment, with Nordson’s share price up 4.75% over the past week and delivering a 52.01% 1 year total shareholder return, while the...
NasdaqGS:ADUS
NasdaqGS:ADUSHealthcare

What Does a Small Insider Sale Reveal About Addus HomeCare’s Regulatory Tailwind Story (ADUS)?

On May 19, 2026, Addus HomeCare director Esteban Lopez sold 250 shares of common stock in an open-market transaction at US$93.00 per share, leaving him with a remaining direct holding of roughly 3,200–3,450 shares disclosed in recent SEC Form 4 filings. At the same time, analysts highlight that Addus HomeCare may benefit from regulatory pressure on self-directed operators and an aging U.S. population, potentially widening its opportunity to acquire client books and grow its home-care...
NYSE:NYT
NYSE:NYTMedia

Is It Too Late To Consider New York Times (NYT) After Its Strong Multi Year Rally?

Wondering if New York Times stock at around US$74.96 is still offering value after a strong multi year run, or if most of the upside is already reflected in the price. The stock is up 7.4% year to date and 36.9% over the past year, although it has fallen 2.2% over the last week and is down 7.3% over the past month, which may have some investors reassessing the balance between upside and risk. Recent coverage has focused on New York Times as a long established media brand adapting to a...
NasdaqGS:MANH
NasdaqGS:MANHSoftware

What Manhattan Associates (MANH)'s New AI Suite and Exol Partnership Means For Shareholders

In May 2026, Manhattan Associates Inc. rolled out a suite of AI-focused upgrades, including Sightline explainable forecasting, the Solution Design Studio configuration workspace, and the Manhattan Marketplace ecosystem, while Exol announced it will deploy Manhattan’s warehouse and transportation platforms across its AI-enabled fulfillment network backed by a very large US$7,500 million commitment from SoftBank Group and Symbotic. Together, these moves push Manhattan’s platform deeper into...
NasdaqGS:JBLU
NasdaqGS:JBLUAirlines

Why JetBlue (JBLU) Is Up 10.3% After Deepening United Tie-Up and Launching Milan Route - And What's Next

Earlier in May 2026, JetBlue Airways and United Airlines announced expanded Blue Sky collaboration benefits, giving TrueBlue and MileagePlus members reciprocal elite-style perks plus integrated earning, redemption, and booking across both networks. At the same time, JetBlue launched its first-ever Italy route with daily Boston–Milan service, underscoring its push into higher-touch transatlantic flying while reinforcing its loyalty ecosystem. Next, we’ll examine how this deeper United...
NasdaqGS:ROIV
NasdaqGS:ROIVBiotechs

Roivant Shelf Plan Raises Questions On Dilution And Pipeline Funding

Roivant Sciences (NasdaqGS:ROIV) has filed a shelf registration that would allow it to issue nearly $1 billion in new common shares. The filing provides the company with flexibility to conduct future equity offerings when market conditions and funding needs align. This potential issuance could affect shareholder dilution, capital raising plans, and Roivant's ability to fund future projects. Roivant Sciences enters this development with its share price at $29.96 and very large multi-year...
NYSE:VZ
NYSE:VZTelecom

The Bull Case For Verizon (VZ) Could Change Following New Satellite JV And $4 Billion Note Sale - Learn Why

Earlier in May 2026, Verizon Communications closed the sale of US$2.00 billion each of 6.050% and 6.200% junior subordinated notes and, days later, joined AT&T and T-Mobile in announcing an agreement in principle for a joint venture to extend U.S. mobile coverage via satellite-based, direct-to-device technologies. This push into satellite-enabled connectivity, alongside fresh long-term funding, highlights Verizon’s effort to broaden network reach, support rural coverage, and create a shared...
NYSE:LLY
NYSE:LLYPharmaceuticals

A Look At Eli Lilly (LLY) Valuation After Retatrutide’s Strong Phase 3 Obesity Trial Results

Eli Lilly (LLY) is back in the spotlight after its investigational obesity drug retatrutide hit strong Phase 3 trial milestones, showing high and durable weight loss and sharpening investor focus on the company’s obesity franchise. See our latest analysis for Eli Lilly. The recent retatrutide headlines and broader cardiometabolic data have come alongside firm share price momentum, with a 1 month share price return of 20.48% and a 1 year total shareholder return of 50.28%. The year to date...
NYSE:AB
NYSE:ABCapital Markets

A Look At AllianceBernstein (AB) Valuation As Recent Trading Leaves Shares Near Analyst Fair Value Estimates

AllianceBernstein Holding stock update AllianceBernstein Holding (AB) stock has drawn fresh attention after recent trading left it around $37.93, with returns down over the past month and past 3 months but positive over the past year. See our latest analysis for AllianceBernstein Holding. Short term, the stock has slipped, with the 30 day share price return down 2.29% and year to date share price return down 1.84%, while the 1 year total shareholder return of 5.54% and 3 year total...
NasdaqGS:BILI
NasdaqGS:BILIInteractive Media and Services

Is It Time To Reassess Bilibili (BILI) After The Recent Share Price Slump?

Wondering whether Bilibili at a last close of US$17.23 still lines up with what you think it is worth, or if the recent share price is sending a different signal about value? The stock has been under pressure recently, with the share price down 12.2% over the past week, 22.6% over the past month, 34.7% year to date, and 9.0% over the last year, while still showing a 2.0% gain over three years and a much larger 83.9% decline over five years. These moves come against a backdrop of ongoing...
NasdaqGS:PTRN
NasdaqGS:PTRNMultiline Retail

Pattern Group Patent And AI Engine Shape Ecommerce Growth And Valuation Story

Pattern Group (NasdaqGS:PTRN) received a key U.S. patent for its True ROAS advertising measurement technology, covering how it tracks and attributes advertising effectiveness. The company also launched Pi, an AI powered autonomous ecommerce execution engine built on its proprietary data and retail expertise. These developments expand Pattern Group's adtech and ecommerce tools for brand partners and may influence how investors view its technology and growth approach. Pattern Group focuses on...
NasdaqGS:MPWR
NasdaqGS:MPWRSemiconductor

Monolithic Power Systems (MPWR) Is Up 7.0% After AI-Fueled Earnings Beat And Upbeat Outlook - What's Changed

In the past few days, Monolithic Power Systems reported quarterly results that exceeded expectations, with revenue rising 26.1% year over year and adjusted earnings beating forecasts, supported by strong demand in communications and enterprise data markets tied to servers and AI-related deployments. The company’s upbeat outlook, particularly around AI-driven enterprise data and communications demand, has reinforced the view that AI infrastructure is becoming a central engine of its business...
NYSE:HWM
NYSE:HWMAerospace & Defense

A Look At Howmet Aerospace (HWM) Valuation After Record High Breakout On Q1 2026 Earnings

Record Q1 Earnings Spark Technical Breakout in Howmet Aerospace Stock Howmet Aerospace (HWM) shares reacted to a robust Q1 2026 earnings report with a technical breakout to record highs, as growth metrics and chart signals pulled attention to the stock’s recent move. See our latest analysis for Howmet Aerospace. Beyond the Q1 2026 breakout, Howmet Aerospace’s share price has risen 21.18% year to date to US$256.55, while its one-year total shareholder return of 55.75% signals strong momentum...
NYSE:HIMS
NYSE:HIMSHealthcare

A Look At Hims & Hers Health (HIMS) Valuation As Canada GLP 1 Launch Expands Its Reach

Hims & Hers Health (HIMS) has begun offering generic semaglutide to eligible customers in Canada after Health Canada authorization, expanding its international reach and directly targeting demand in diabetes and weight management treatments. See our latest analysis for Hims & Hers Health. At a share price of $23.75, Hims & Hers Health has seen short term volatility, with the 30 day share price return down 22.28% and the 90 day return up 53.62%. The three year total shareholder return of...
NasdaqGS:STX
NasdaqGS:STXTech

Does Seagate (STX) Using Debt-for-Equity Swaps Signal a New AI-Era Capital Strategy?

Earlier in May, Seagate Technology Holdings and its subsidiary Seagate HDD Cayman privately exchanged US$185.91 million of 3.50% Exchangeable Senior Notes due 2028 for a mix of cash and ordinary shares, retiring those securities while leaving roughly US$185.80 million of the notes outstanding on unchanged terms. This balance-sheet move, alongside insider share sales and strong enthusiasm around AI-driven storage demand, highlights how capital structure and sentiment are evolving as investors...
NasdaqGS:COLM
NasdaqGS:COLMLuxury

Cooling Yields Lift Columbia Sportswear (COLM) Shares And Put Fresh Focus On Its Valuation Potential

Cooling Treasury yields and progress in Iran peace talks eased inflation worries on Tuesday, lifting investor appetite for discretionary stocks and putting fresh attention on Columbia Sportswear (COLM) after its 3% afternoon move. See our latest analysis for Columbia Sportswear. That 3.3% one day share price move fits into a broader pattern where Columbia Sportswear has a 7 day share price return of 7.13% and a year to date share price return of 13.14%. This comes even as the 3 year total...
NYSE:XPO
NYSE:XPOTransportation

Assessing XPO (XPO) Valuation After Strong Long Term Returns And A Recent Pullback

What XPO’s Recent Performance Signals for Investors XPO (XPO) has drawn attention after a strong year to date return of 46.2%, even as the stock is down about 9.3% over the past month and roughly 0.8% over the past 3 months. See our latest analysis for XPO. The recent share price pullback of about 9% over the past month comes after a strong year to date share price return of 46.2%, while the 1 year total shareholder return of 73.4% and 3 year total shareholder return above 3x suggest longer...
NasdaqCM:IGIC
NasdaqCM:IGICInsurance

A Look At International General Insurance Holdings (IGIC) Valuation After Its 50% Dividend Increase

International General Insurance Holdings (IGIC) has drawn fresh attention after its board approved a 50% increase in the quarterly dividend to $0.075 per share. This change will be effective for shareholders of record on May 28, 2026. See our latest analysis for International General Insurance Holdings. The stock’s recent 1 day share price return declined 2.3% to $25.31. However, the 1 year total shareholder return of 16.0% and very large 3 and 5 year total shareholder returns suggest...